These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 20646746
1. Resistive index as risk factor for acute urinary retention in patients with benign prostatic hyperplasia. Shinbo H, Kurita Y, Takada S, Imanishi T, Otsuka A, Furuse H, Nakanishi T, Mugiya S, Ozono S. Urology; 2010 Dec; 76(6):1440-5. PubMed ID: 20646746 [Abstract] [Full Text] [Related]
2. Evaluation of resistive index of the prostate and bladder sonomorphologic parameters as replacements for urodynamics to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Garg G, Sankhwar SN, Goel A, Pandey S, Sharma D, Parihar A. Low Urin Tract Symptoms; 2019 May; 11(3):163-168. PubMed ID: 30793849 [Abstract] [Full Text] [Related]
8. Ultrasonic measurement of bladder weight as a possible predictor of acute urinary retention in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Miyashita H, Kojima M, Miki T. Ultrasound Med Biol; 2002 Aug; 28(8):985-90. PubMed ID: 12217433 [Abstract] [Full Text] [Related]
10. [The relationship between intravesical prostatic protrusion and pressure flow study findings in patients with benign prostate obstruction/lower urinary tract symptoms]. Park SC, Lee JW, Rim JS. Actas Urol Esp; 2012 Mar; 36(3):165-70. PubMed ID: 22018947 [Abstract] [Full Text] [Related]
13. [Serum PSA and transition zone index as predictors of acute urinary retention in benign prostate hyperplasia]. Zhu S, Chen S, Li Q, Lin Z, Zheng S, Weng M. Zhonghua Nan Ke Xue; 2004 Jan; 10(1):24-5. PubMed ID: 14979202 [Abstract] [Full Text] [Related]
15. Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction. Kojima M, Ochiai A, Naya Y, Okihara K, Ukimura O, Miki T. Eur Urol; 2000 Apr; 37(4):436-42. PubMed ID: 10765074 [Abstract] [Full Text] [Related]
19. The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy. Crook J, Toi A, McLean M, Pond G. Brachytherapy; 2002 Apr; 1(3):131-7. PubMed ID: 15090275 [Abstract] [Full Text] [Related]
20. Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily. Emberton M, Elhilali M, Matzkin H, Harving N, van Moorselaar J, Hartung R, Alcaraz A, Vallancien G, Alf-One Study Group. Urology; 2005 Aug; 66(2):316-22. PubMed ID: 16098361 [Abstract] [Full Text] [Related] Page: [Next] [New Search]